Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3409526
Max Phase: Preclinical
Molecular Formula: C22H34Li2N3O7P
Molecular Weight: 485.52
Molecule Type: Small molecule
Associated Items:
ID: ALA3409526
Max Phase: Preclinical
Molecular Formula: C22H34Li2N3O7P
Molecular Weight: 485.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NP(=O)([O-])CNC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)(C)C)C(=O)[O-].[Li+].[Li+]
Standard InChI: InChI=1S/C22H36N3O7P.2Li/c1-15(2)11-17(19(26)24-18(20(27)28)12-22(3,4)5)25-33(30,31)14-23-21(29)32-13-16-9-7-6-8-10-16;;/h6-10,15,17-18H,11-14H2,1-5H3,(H,23,29)(H,24,26)(H,27,28)(H2,25,30,31);;/q;2*+1/p-2/t17-,18-;;/m0../s1
Standard InChI Key: LPWZBBGQRBOMNK-MPGISEFESA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 485.52 | Molecular Weight (Monoisotopic): 485.2291 | AlogP: 3.07 | #Rotatable Bonds: 12 |
Polar Surface Area: 154.06 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.03 | CX Basic pKa: | CX LogP: 2.74 | CX LogD: -2.52 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.28 | Np Likeness Score: 0.03 |
1. Nasief NN, Hangauer D.. (2015) Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?, 90 [PMID:25559080] [10.1016/j.ejmech.2014.11.056] |
Source(1):